Navidea Biopharmaceuticals Company
Navidea Biopharmaceuticals is a leader in precision medicine with immuno-targeted products designed to help identify the sites.
Technology:
Personalised Medicine
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Founded Date:
1983-01-01
Employees Number:
11-50
Funding Status:
IPO
Acquisitions Number:
1
Investors Number:
2
Total Funding:
$92.5M
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership